The test to detect HER2 gene amplification status is considered positive if the ratio of the HER2 gene copy number per tumor cell to the chromosome 17 copy number is greater than or equal to 2 (HER2/CEP17-Ratio ≥2) (Summary of Product Characteristics Herceptin® i.v. 2015). This evidence concerns the gene ERBB2 and neoplasm.